Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

DSGNDSGN
Showing 8 of 22 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in DESIGN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 958,417 shares of DSGN (DESIGN THERAPEUTICS INC), worth $13.9M as of 2026-Q2. The position was increased (+38.4% shares). DSGN represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$13.9M

Current Shares

958,417

Total Value Change

+$9.8M

Total Shares Change

+199,867

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
958,417
+38.4%
$13.9M0.0%$14.47
37
2026-Q1
Increased
692,518
+1.9%
$7.4M0.0%$10.00
28
2025-Q4
Decreased
679,590
-2.3%
$6.4M0.0%$9.79
0
2025-Q3
Decreased
695,613
-12.4%
$5.2M0.0%$6.85
0
2025-Q2
Increased
794,008
+2.4%
$2.7M0.0%$3.57
27
2025-Q1
Increased
775,497
+1.8%
$3M0.0%$4.21
27
2024-Q4
Increased
761,640
+0.4%
$4.7M0.0%$6.17
27
2024-Q3
Increased
758,550
+7.1%
$4.1M0.0%$5.33
29

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used